Hepatocellular carcinoma (HCC) is the most common type of liver cancer. It is a major global health concern with rising rates, particularly in North Africa and East Asia.
Oncolytics targets accelerated approval for oncolytic virus therapy
Oncolytics’s pelareorep is an intravenously delivered oncolytic reovirus that specifically targets cancer cells and induces inflammatory responses. Image credit: MiniStocker / Shutterstock. Oncolytics Biotech is